C. Silva, Ueslei Menezes de Araujo, M. Alvaia, K. S. Freitas, T. Tiraboschi, C. Gomes, J. B. Bessa Júnior
{"title":"Luts-V:一种评估男性下尿路症状的新的简化评分","authors":"C. Silva, Ueslei Menezes de Araujo, M. Alvaia, K. S. Freitas, T. Tiraboschi, C. Gomes, J. B. Bessa Júnior","doi":"10.1101/2020.05.05.20091835","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To validate a new simplified score for the assessment of men with LUTS (LUTS-V). METHODS: We made adjustments to the VPSS, resulting in a new simplified instrument (LUTS visual score - LUTS-V). In a pilot study, LUTS-V was administered to 50 men to identify interpretation issues. We used the International Prostate Symptom Score (IPSS) as the gold standard to validate the new tool in 306 men. The total IPSS and LUTS-V scores for each subject were evaluated and we used Bland-Altman analysis and Pearson's correlation plot to assess the agreement between the scores. A ROC curve was utilized to determine the diagnostic accuracy of LUTS-V and its diagnostic properties were described in terms of sensitivity, specificity, positive, and negative predictive values. RESULTS: Median age was 59 [52-67] years and, according to the IPSS, 26 (8.7%) patients had severe symptoms, while 99 (33%) had moderate symptoms, and 175 (58.3%) had mild symptoms. We found a positive correlation between the IPSS and LUTS-V (r = 0.72; p < 0.0001). The bland-Altman analysis showed good agreement between the two questionnaires. We found LUTS-V to have a diagnostic accuracy to detect more severe cases of 83% (95% CI: [78-87%]; p < 0.001), as estimated by the area under the ROC curve. The cut-off value of [≥] 4 points was the best threshold, with a sensitivity of 74% and a specificity of 78%, which resulted in a negative predictive value of 81% and a positive predictive value of 71% in this scenario. Median completion time was 0.51 [0.41-1.07] min for LUTS-V and 2.5 [2.2-3.4] min for the IPSS (p < 0.0001). Also, 91.5% of patients completed the questionnaires with no help, while the other 8.5% were interviewed. CONCLUSION: LUTS-V is a simple, self-administered tool with a significant discriminating power to identify patients with moderate to severe symptoms.","PeriodicalId":13674,"journal":{"name":"International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology","volume":"22 1","pages":"525 - 532"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Luts-V: A new simplified score for assessing lower urinary tract symptoms in men\",\"authors\":\"C. Silva, Ueslei Menezes de Araujo, M. Alvaia, K. S. Freitas, T. Tiraboschi, C. Gomes, J. B. Bessa Júnior\",\"doi\":\"10.1101/2020.05.05.20091835\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVE: To validate a new simplified score for the assessment of men with LUTS (LUTS-V). METHODS: We made adjustments to the VPSS, resulting in a new simplified instrument (LUTS visual score - LUTS-V). In a pilot study, LUTS-V was administered to 50 men to identify interpretation issues. We used the International Prostate Symptom Score (IPSS) as the gold standard to validate the new tool in 306 men. The total IPSS and LUTS-V scores for each subject were evaluated and we used Bland-Altman analysis and Pearson's correlation plot to assess the agreement between the scores. A ROC curve was utilized to determine the diagnostic accuracy of LUTS-V and its diagnostic properties were described in terms of sensitivity, specificity, positive, and negative predictive values. RESULTS: Median age was 59 [52-67] years and, according to the IPSS, 26 (8.7%) patients had severe symptoms, while 99 (33%) had moderate symptoms, and 175 (58.3%) had mild symptoms. We found a positive correlation between the IPSS and LUTS-V (r = 0.72; p < 0.0001). The bland-Altman analysis showed good agreement between the two questionnaires. We found LUTS-V to have a diagnostic accuracy to detect more severe cases of 83% (95% CI: [78-87%]; p < 0.001), as estimated by the area under the ROC curve. The cut-off value of [≥] 4 points was the best threshold, with a sensitivity of 74% and a specificity of 78%, which resulted in a negative predictive value of 81% and a positive predictive value of 71% in this scenario. Median completion time was 0.51 [0.41-1.07] min for LUTS-V and 2.5 [2.2-3.4] min for the IPSS (p < 0.0001). Also, 91.5% of patients completed the questionnaires with no help, while the other 8.5% were interviewed. CONCLUSION: LUTS-V is a simple, self-administered tool with a significant discriminating power to identify patients with moderate to severe symptoms.\",\"PeriodicalId\":13674,\"journal\":{\"name\":\"International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology\",\"volume\":\"22 1\",\"pages\":\"525 - 532\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2020.05.05.20091835\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2020.05.05.20091835","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Luts-V: A new simplified score for assessing lower urinary tract symptoms in men
OBJECTIVE: To validate a new simplified score for the assessment of men with LUTS (LUTS-V). METHODS: We made adjustments to the VPSS, resulting in a new simplified instrument (LUTS visual score - LUTS-V). In a pilot study, LUTS-V was administered to 50 men to identify interpretation issues. We used the International Prostate Symptom Score (IPSS) as the gold standard to validate the new tool in 306 men. The total IPSS and LUTS-V scores for each subject were evaluated and we used Bland-Altman analysis and Pearson's correlation plot to assess the agreement between the scores. A ROC curve was utilized to determine the diagnostic accuracy of LUTS-V and its diagnostic properties were described in terms of sensitivity, specificity, positive, and negative predictive values. RESULTS: Median age was 59 [52-67] years and, according to the IPSS, 26 (8.7%) patients had severe symptoms, while 99 (33%) had moderate symptoms, and 175 (58.3%) had mild symptoms. We found a positive correlation between the IPSS and LUTS-V (r = 0.72; p < 0.0001). The bland-Altman analysis showed good agreement between the two questionnaires. We found LUTS-V to have a diagnostic accuracy to detect more severe cases of 83% (95% CI: [78-87%]; p < 0.001), as estimated by the area under the ROC curve. The cut-off value of [≥] 4 points was the best threshold, with a sensitivity of 74% and a specificity of 78%, which resulted in a negative predictive value of 81% and a positive predictive value of 71% in this scenario. Median completion time was 0.51 [0.41-1.07] min for LUTS-V and 2.5 [2.2-3.4] min for the IPSS (p < 0.0001). Also, 91.5% of patients completed the questionnaires with no help, while the other 8.5% were interviewed. CONCLUSION: LUTS-V is a simple, self-administered tool with a significant discriminating power to identify patients with moderate to severe symptoms.